217 related articles for article (PubMed ID: 339354)
1. Immune reactivity in head and neck squamous carcinoma and relevance to the design of immunotherapy trials.
Browder JP; Chretien PB
Semin Oncol; 1977 Dec; 4(4):431-9. PubMed ID: 339354
[No Abstract] [Full Text] [Related]
2. Effects of combined immunotherapy with levamisole and Bacillus Calmette-Guérin on immunocompetence of patients with squamous cell carcinoma of the cervix, head and neck, and lung undergoing radiation therapy.
Olkowski ZL; McLaren JR; Skeen MJ
Cancer Treat Rep; 1978 Nov; 62(11):1651-61. PubMed ID: 310339
[TBL] [Abstract][Full Text] [Related]
3. Adjuvant immuno- and/or chemotherapy with neuraminidase-treated autogenous tumor vaccine and Bacillus Calmette-Guérin for head and neck cancers.
Cunningham TJ; Antemann R; Paonessa D; Sponzo RW; Steiner D
Ann N Y Acad Sci; 1976; 277(00):339-44. PubMed ID: 1069553
[No Abstract] [Full Text] [Related]
4. Levamisole in squamous cell carcinoma of the head and neck.
Olivari AJ; Glait HM; Guardo A; Califano L; Pradier R
Cancer Treat Rep; 1979 Jun; 63(6):983-90. PubMed ID: 380804
[TBL] [Abstract][Full Text] [Related]
5. Immunologic evaluation and prognosis in patients with head and neck cancer.
Hilal EY; Wanebo HJ; Pinsky CM; Middleman P; Strong EW; Oettgen HF
Am J Surg; 1977 Oct; 134(4):468-73. PubMed ID: 303057
[TBL] [Abstract][Full Text] [Related]
6. Cellular immunity in patients with epidermoid cancer of the head and neck.
Papenhausen PR; Kukwa A; Croft CB; Borowiecki B; Silver C; Emeson EE
Laryngoscope; 1979 Apr; 89(4):538-49. PubMed ID: 311881
[TBL] [Abstract][Full Text] [Related]
7. Unspecific cellular immunity before therapy in patients with squamous cell carcinoma of head and neck.
Bier J; Bitter K; Nicklisch U
J Maxillofac Surg; 1978 May; 6(2):75-93. PubMed ID: 353210
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of levamisole in patients with squamous cancer of the head and neck: a preliminary report.
Wanebo HJ; Hilal EY; Pinsky CM; Strong EW; Mike V; Hirshaut Y; Oettgen HF
Cancer Treat Rep; 1978 Nov; 62(11):1663-9. PubMed ID: 365322
[TBL] [Abstract][Full Text] [Related]
9. Immunobiology of head and neck cancer: basic concepts.
Wanebo HJ
Head Neck Surg; 1979; 2(1):42-55. PubMed ID: 400659
[TBL] [Abstract][Full Text] [Related]
10. Results of BCG adjuvant immunotherapy in 100 patients with epidermoid carcinoma of the head and neck.
Suen JY; Richman SP; Livingston RB; Hersh EM; Craig R; Tonymon K
Am J Surg; 1977 Oct; 134(4):474-8. PubMed ID: 911030
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy: a new alternative treatment for head and neck squamous cell carcinoma].
Bron L; Romero P
Bull Cancer; 2007 Sep; 94(9):793-7. PubMed ID: 17878099
[TBL] [Abstract][Full Text] [Related]
12. Unique immunobiological aspects of head and neck squamous carcinoma.
Chretien PB
Can J Otolaryngol; 1975; 4(2):225-35. PubMed ID: 166742
[TBL] [Abstract][Full Text] [Related]
13. A correlative analysis of in vitro parameters of cellular immunity in patients with squamous cell carcinoma of the head and neck.
Deegan MJ; Coulthard SW; Quaiman SJ; Schork MA
Cancer Res; 1977 Dec; 37(12):4475-81. PubMed ID: 144562
[No Abstract] [Full Text] [Related]
14. Immunotherapy for Head and Neck Squamous Cell Carcinoma: A Review of Current and Emerging Therapeutic Options.
Moskovitz JM; Moy J; Seiwert TY; Ferris RL
Oncologist; 2017 Jun; 22(6):680-693. PubMed ID: 28507203
[TBL] [Abstract][Full Text] [Related]
15. BCG in cancer therapy: theoretical bases of immunotherapy.
Dodd MJ
Am J Nurs; 1979 Feb; 79(2):310-4. PubMed ID: 311587
[No Abstract] [Full Text] [Related]
16. Expansion of tumor-infiltrating lymphocytes from human solid tumors in interleukin-2.
Whiteside TL; Heo DS; Chen K; Adler A; Johnson JT; Herberman RB
Prog Clin Biol Res; 1987; 244():213-22. PubMed ID: 3309998
[No Abstract] [Full Text] [Related]
17. [Investigations of unspecific immune reactivity in patients with head and neck carcinoma (author's transl)].
Bier J; Nicklisch U
Arch Otorhinolaryngol; 1981; 232(2):145-63. PubMed ID: 6973965
[TBL] [Abstract][Full Text] [Related]
18. Proceedings: Cellular immunity in cured cancer patients.
Twomey PL; Catalona WJ; Chretien PB
Cancer; 1974 Feb; 33(2):435-40. PubMed ID: 4812762
[No Abstract] [Full Text] [Related]
19. The usefulness of pretreatment DNCB in 85 patients with squamous cell carcinoma of the upper aerodigestive tract.
Gilbert HA; Kagan AR; Miles J; Flores L; Nussbaum H; Rao AR; Chan P
J Surg Oncol; 1978; 10(1):73-7. PubMed ID: 628221
[TBL] [Abstract][Full Text] [Related]
20. Correlation of immune reactivity and clinical status in cancer.
Chretien PB; Catalona WJ; Twomey PL; Sample WF
Ann Clin Lab Sci; 1974; 4(5):331-8. PubMed ID: 4851196
[No Abstract] [Full Text] [Related]
[Next] [New Search]
